Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function

Journal of Cell Science

Volumn 125, Issue 24, 2012, Pages 6084-6093

  Atapattu, Lakmali ^a   Saha, Nayanendu ^b   Llerena, Carmen ^a   Vail, Mary E ^a   Scott, Andrew M ^c   Nikolov, Dimitar B ^b   Lackmann, Martin ^a   Janes, Peter W ^a  

^a MONASH UNIVERSITY   (Australia)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

ADAM metalloprotease; Cell cell adhesion; Eph receptor; Ephrin cleavage

Indexed keywords

ADAM10 ENDOPEPTIDASE; ANTIBODY; EPHRIN; EPHRIN A RECEPTOR; EPHRIN B RECEPTOR; EPHRIN RECEPTOR; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; ADAM PROTEIN; PROTEIN BINDING;

ANTIBODY SPECIFICITY; ARTICLE; CELL DIVISION; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; INTERNALIZATION; MEDIATOR; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ANIMAL; ANTIBODY COMBINING SITE; BOVINAE; CELL ADHESION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ADAM PROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; CATTLE; CELL ADHESION; EPHRINS; HEK293 CELLS; HUMANS; MICE; PROTEIN BINDING; RECEPTORS, EPH FAMILY; SIGNAL TRANSDUCTION;

EID: 84875602708     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.112631     Document Type: Article

References (50)

1. Blobel, C. P. (2005). ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6, 32-43.
2. DasGupta, S., Murumkar, P. R., Giridhar, R. and Yadav, M. R. (2009). Current perspective of TACE inhibitors: a review. Bioorg. Med. Chem. 17, 444-459.
3. Dobrowolski, R. and De Robertis, E. M. (2012). Endocytic control of growth factor signalling: multivesicular bodies as signalling organelles. Nat. Rev. Mol. Cell Biol. 13, 53-60.
4. Fischer, O. M., Hart, S., Gschwind, A. and Ullrich, A. (2003). EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 31, 1203-1208.
5. Guan, H.-H., Goh, K.-S., Davamani, F., Wu, P.-L., Huang, Y.-W., Jeyakanthan, J., Wu, W.-G. and Chen, C.-J. (2010). Structures of two elapid snake venom metalloproteases with distinct activities highlight the disulfide patterns in the D domain of ADAMalysin family proteins. J. Struct. Biol. 169, 294-303.
6. Hartmann, D., de Strooper, B., Serneels, L., Craessaerts, K., Herreman, A., Annaert, W., Umans, L., Lübke, T., Lena Illert, A., von Figura, K. et al. (2002). The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for a-secretase activity in fibroblasts. Hum. Mol. Genet. 11, 2615-2624.
7. Hattori, M., Osterfield, M. and Flanagan, J. G. (2000). Regulated cleavage of a contact-mediated axon repellent. Science 289, 1360-1365.
8. Himanen, J. P., Chumley, M. J., Lackmann, M., Li, C., Barton, W. A., Jeffrey, P. D., Vearing, C., Geleick, D., Feldheim, D. A., Boyd, A. W. et al. (2004). Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat. Neurosci. 7, 501-509.
9. Holmberg, J., Clarke, D. L. and Frisén, J. (2000). Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature 408, 203-206.
10. Howard, L., Lu, X., Mitchell, S., Griffiths, S. and Glynn, P. (1996). Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. Biochem. J. 317, 45-50.
11. Janes, P. W., Saha, N., Barton, W. A., Kolev, M. V., Wimmer-Kleikamp, S. H., Nievergall, E., Blobel, C. P., Himanen, J. P., Lackmann, M. and Nikolov, D. B. (2005). Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123, 291-304.
12. Janes, P. W., Wimmer-Kleikamp, S. H., Frangakis, A. S., Treble, K., Griesshaber, B., Sabet, O., Grabenbauer, M., Ting, A. Y., Saftig, P., Bastiaens, P. I. et al. (2009). Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol. 7, e1000215.
13. Janes, P. W., Griesshaber, B., Atapattu, L., Nievergall, E., Hii, L. L., Mensinga, A., Chheang, C., Day, B. W., Boyd, A. W., Bastiaens, P. I. et al. (2011). Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors. J. Cell Biol. 195, 1033-1045.
14. Jørgensen, C., Sherman, A., Chen, G. I., Pasculescu, A., Poliakov, A., Hsiung, M., Larsen, B., Wilkinson, D. G., Linding, R. and Pawson, T. (2009). Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science 326, 1502-1509.
15. Knöll, B., Weinl, C., Nordheim, A. and Bonhoeffer, F. (2007). Stripe assay to examine axonal guidance and cell migration. Nat. Protoc. 2, 1216-1224.
16. Lackmann, M., Bucci, T., Mann, R. J., Kravets, L. A., Viney, E., Smith, F., Moritz, R. L., Carter, W., Simpson, R. J., Nicola, N. A. et al. (1996). Purification of a ligand for the EPH-like receptor HEK using a biosensor-based affinity detection approach. Proc. Natl. Acad. Sci. USA 93, 2523-2527.
17. Lawrenson, I. D., Wimmer-Kleikamp, S. H., Lock, P., Schoenwaelder, S. M., Down, M., Boyd, A. W., Alewood, P. F. and Lackmann, M. (2002). Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling. J. Cell Sci. 115, 1059-1072.
18. Lemmon, V., Farr, K. L. and Lagenaur, C. (1989). L1-mediated axon outgrowth occurs via a homophilic binding mechanism. Neuron 2, 1597-1603.
19. Liu, P. C., Liu, X., Li, Y., Covington, M., Wynn, R., Huber, R., Hillman, M., Yang, G., Ellis, D., Marando, C. et al. (2006). Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells. Cancer Biol. Ther. 5, 657-664.
20. Marcello, E., Gardoni, F., Di Luca, M. and Pérez-Otaño, I. (2010). An arginine stretch limits ADAM10 exit from the endoplasmic reticulum. J. Biol. Chem. 285, 10376-10384.
21. Marston, D. J., Dickinson, S. and Nobes, C. D. (2003). Rac-dependent transendocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat. Cell Biol. 5, 879-888.
22. Maskos, K., Fernandez-Catalan, C., Huber, R., Bourenkov, G. P., Bartunik, H., Ellestad, G. A., Reddy, P., Wolfson, M. F., Rauch, C. T., Castner, B. J. et al. (1998). Crystal structure of the catalytic domain of human tumor necrosis factor-aconverting enzyme. Proc. Natl. Acad. Sci. USA 95, 3408-3412.
23. Mellitzer, G., Xu, Q. and Wilkinson, D. G. (1999). Eph receptors and ephrins restrict cell intermingling and communication. Nature 400, 77-81.
24. Moss, M. L., White, J. M., Lambert, M. H. and Andrews, R. C. (2001). TACE and other ADAM proteases as targets for drug discovery. Drug Discov. Today 6, 417-426.
25. Murphy, G. (2008). The ADAMs: signalling scissors in the tumour microenvironment. Nat. Rev. Cancer 8, 932-941.
26. Nievergall, E., Janes, P. W., Stegmayer, C., Vail, M. E., Haj, F. G., Teng, S. W., Neel, B. G., Bastiaens, P. I. and Lackmann, M. (2010). PTP1B regulates Eph receptor function and trafficking. J. Cell Biol. 191, 1189-1203.
27. Nievergall, E., Lackmann, M. and Janes, P. W. (2012). Eph-dependent cell-cell adhesion and segregation in development and cancer. Cell. Mol. Life Sci. 69, 1813- 1842.
28. Oakley, F. D., Abbott, D., Li, Q. and Engelhardt, J. F. (2009). Signaling components of redox active endosomes: the redoxosomes. Antioxid. Redox Signal. 11, 1313-1333.
29. Pasquale, E. B. (2010). Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165-180.
30. Poliakov, A., Cotrina, M. and Wilkinson, D. G. (2004). Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev. Cell 7, 465- 480.
31. Poliakov, A., Cotrina, M. L., Pasini, A. and Wilkinson, D. G. (2008). Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway. J. Cell Biol. 183, 933-947.
32. Reddy, P., Slack, J. L., Davis, R., Cerretti, D. P., Kozlosky, C. J., Blanton, R. A., Shows, D., Peschon, J. J. and Black, R. A. (2000). Functional analysis of the domain structure of tumor necrosis factor-a converting enzyme. J. Biol. Chem. 275, 14608- 14614.
33. 2, a necessary evil for cell signaling. Science 312, 1882-1883.
34. Rio, C., Buxbaum, J. D., Peschon, J. J. and Corfas, G. (2000). Tumor necrosis factora α-converting enzyme is required for cleavage of erbB4/HER4. J. Biol. Chem. 275, 10379-10387.
35. Saftig, P. and Reiss, K. (2011). The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur. J. Cell Biol. 90, 527-535.
36. Salaita, K., Nair, P. M., Petit, R. S., Neve, R. M., Das, D., Gray, J. W. and Groves, J. T. (2010). Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 327, 1380-1385.
37. Sanderson, M. P., Dempsey, P. J. and Dunbar, A. J. (2006). Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Growth Factors 24, 121-136.
38. Sardi, S. P., Murtie, J., Koirala, S., Patten, B. A. and Corfas, G. (2006). Presenilindependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127, 185-197.
39. Scita, G. and Di Fiore, P. P. (2010). The endocytic matrix. Nature 463, 464-473.
40. Smith, K. M., Gaultier, A., Cousin, H., Alfandari, D., White, J. M. and DeSimone, D. W. (2002). The cysteine-rich domain regulates ADAM protease function in vivo. J. Cell Biol. 159, 893-902.
41. Solanas, G., Cortina, C., Sevillano, M. and Batlle, E. (2011). Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat. Cell Biol. 13, 1100-1107.
42. Tiganis, T. (2011). Reactive oxygen species and insulin resistance: the good, the bad and the ugly. Trends Pharmacol. Sci. 32, 82-89.
43. Ushio-Fukai, M. (2009). Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid. Redox Signal. 11, 1289-1299.
44. Vearing, C., Lee, F. T., Wimmer-Kleikamp, S., Spirkoska, V., To, C., Stylianou, C., Spanevello, M., Brechbiel, M., Boyd, A. W., Scott, A. M. et al. (2005). Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. Cancer Res. 65, 6745-6754.
45. Walter, J., Kern-Veits, B., Huf, J., Stolze, B. and Bonhoeffer, F. (1987). Recognition of position-specific properties of tectal cell membranes by retinal axons in vitro. Development 101, 685-696.
46. Wang, Y., Herrera, A. H., Li, Y., Belani, K. K. and Walcheck, B. (2009). Regulation of mature ADAM17 by redox agents for L-selectin shedding. J. Immun. 182, 2449-2457.
47. White, J. M. (2003). ADAMs: modulators of cell-cell and cell-matrix interactions. Curr. Opin. Cell Biol. 15, 598-606.
48. Willems, S. H., Tape, C. J., Stanley, P. L., Taylor, N. A., Mills, I. G., Neal, D. E., McCafferty, J. and Murphy, G. (2010). Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem. J. 428, 439-450.
49. Wimmer-Kleikamp, S. H., Janes, P. W., Squire, A., Bastiaens, P. I. and Lackmann, M. (2004). Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J. Cell Biol. 164, 661-666.
50. Zimmer, M., Palmer, A., Köhler, J. and Klein, R. (2003). EphB-ephrinB bidirectional endocytosis terminates adhesion allowing contact mediated repulsion. Nat. Cell Biol. 5, 869-878.